New York State Common Retirement Fund Cuts Stock Position in Medpace Holdings, Inc. (NASDAQ:MEDP)

New York State Common Retirement Fund lowered its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP) by 5.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 19,828 shares of the company’s stock after selling 1,093 shares during the quarter. New York State Common Retirement Fund owned 0.06% of Medpace worth $6,587,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also bought and sold shares of the company. Iron Triangle Partners LP bought a new position in shares of Medpace in the 3rd quarter valued at about $64,371,000. Wellington Management Group LLP increased its stake in Medpace by 36.0% during the third quarter. Wellington Management Group LLP now owns 415,255 shares of the company’s stock worth $138,612,000 after acquiring an additional 109,886 shares during the last quarter. DF Dent & Co. Inc. raised its position in Medpace by 189.9% during the third quarter. DF Dent & Co. Inc. now owns 161,298 shares of the company’s stock valued at $53,841,000 after purchasing an additional 105,659 shares during the period. Caisse DE Depot ET Placement DU Quebec bought a new stake in shares of Medpace in the 3rd quarter valued at approximately $23,321,000. Finally, International Assets Investment Management LLC boosted its holdings in shares of Medpace by 38,432.9% in the 3rd quarter. International Assets Investment Management LLC now owns 57,414 shares of the company’s stock worth $19,165,000 after purchasing an additional 57,265 shares during the period. Institutional investors own 77.98% of the company’s stock.

Analyst Ratings Changes

Separately, Robert W. Baird raised their price target on Medpace from $354.00 to $362.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $381.44.

Medpace Trading Down 0.4 %

NASDAQ:MEDP opened at $339.48 on Thursday. The stock has a fifty day simple moving average of $343.04 and a 200-day simple moving average of $346.19. The company has a market cap of $10.34 billion, a price-to-earnings ratio of 26.88, a price-to-earnings-growth ratio of 3.81 and a beta of 1.36. Medpace Holdings, Inc. has a twelve month low of $302.01 and a twelve month high of $459.77.

Medpace (NASDAQ:MEDP) last released its quarterly earnings data on Monday, February 10th. The company reported $3.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. As a group, equities research analysts predict that Medpace Holdings, Inc. will post 12.29 EPS for the current fiscal year.

About Medpace

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.